Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05780931 · ClinicalTrials.gov registry record
Rehabilitating Vision Loss in Veterans With Age-Related Macular Degeneration
A clinical trial, sponsored by VA Office of Research and Development.
- Not yet
- Registry status
- 20
- Enrollment target
NCT05780931: Clinical Trial study, sponsored by VA Office of Research and Development.
NCT05780931 is a clinical trial that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05780931 has not yet begun recruiting, sponsored by VA Office of Research and Development.
- NOT YET RECRUITING
- Registry status
- 20 participants
- Enrollment target
Study Summary
This study will help develop new methods of rehabilitating Veterans with vision loss due to Age-related macular degeneration.
Primary Outcome
This outcome will be measured as the accuracy (% correct) with which the study subjects recognize the text objects before, during and after their participation in the study procedures.
Interventions
- BEHAVIORAL Study-specific rehabilitation (SSR) procedures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-08-03 |
| Est. Completion | 2027-05-31 |
What is known before NCT05780931 opens enrollment
NCT05780931 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Study-specific rehabilitation (SSR) procedures is the first listed.
NCT05780931 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05780931 about?
NCT05780931 is a clinical study titled "Rehabilitating Vision Loss in Veterans With Age-Related Macular Degeneration". This study will help develop new methods of rehabilitating Veterans with vision loss due to Age-related macular degeneration.
What is the current status of trial NCT05780931?
This trial is currently not yet recruiting. The enrollment target is 20 participants. The study started on 2026-08-03. Estimated completion is 2027-05-31.
What interventions are being tested in trial NCT05780931?
The interventions under investigation include: Study-specific rehabilitation (SSR) procedures (BEHAVIORAL).
Who is sponsoring clinical trial NCT05780931?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI